10x Genomics Operating Income 2018-2025 | TXG

10x Genomics operating income from 2018 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
10x Genomics Annual Operating Income
(Millions of US $)
2024 $-195
2023 $-265
2022 $-168
2021 $-52
2020 $-534
2019 $-31
2018 $-111
2017 $-18
10x Genomics Quarterly Operating Income
(Millions of US $)
2025-09-30 $-32
2025-06-30 $30
2025-03-31 $-39
2024-12-31 $-50
2024-09-30 $-41
2024-06-30 $-42
2024-03-31 $-61
2023-12-31 $-55
2023-09-30 $-95
2023-06-30 $-63
2023-03-31 $-52
2022-12-31 $-23
2022-09-30 $-40
2022-06-30 $-63
2022-03-31 $-42
2021-12-31 $-16
2021-09-30 $-16
2021-06-30 $-10
2021-03-31 $-10
2020-12-31 $-410
2020-09-30 $-65
2020-06-30 $-39
2020-03-31 $-20
2019-12-31 $-8
2019-09-30 $-9
2019-06-30 $-10
2019-03-31 $-3
2018-12-31
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $2.355B $0.611B
10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $30.189B 34.91
Tempus AI (TEM) United States $9.769B 0.00
Hims & Hers Health (HIMS) United States $5.240B 42.63
Doximity (DOCS) United States $5.221B 22.18
IRhythm Holdings (IRTC) United States $4.719B 0.00
Privia Health (PRVA) United States $2.705B 169.15
Hinge Health (HNGE) United States $2.454B 0.00
Heartflow (HTFL) United States $2.362B 0.00
Inspire Medical Systems (INSP) United States $1.909B 31.59
Omnicell (OMCL) United States $1.664B 46.34
Azenta (AZTA) United States $1.321B 53.19
Enovis (ENOV) United States $1.292B 6.78
Clover Health Investments (CLOV) United States $1.101B 0.00
Schrodinger (SDGR) United States $0.994B 0.00
Butterfly Network (BFLY) United States $0.854B 0.00
Phreesia (PHR) United States $0.736B 0.00
Fulgent Genetics (FLGT) United States $0.725B 0.00
Talkspace (TALK) United States $0.643B 129.33
Standard BioTools (LAB) United States $0.485B 0.00
Claritev (CTEV) United States $0.428B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.324B 0.00
Evolent Health (EVH) United States $0.318B 0.00
Carlsmed (CARL) United States $0.310B 0.00
TruBridge (TBRG) United States $0.304B 13.97
Senseonics Holdings (SENS) United States $0.304B 0.00
Zepp Health (ZEPP) Netherlands $0.256B 0.00
CapsoVision (CV) United States $0.232B 0.00
KORU Medical Systems (KRMD) United States $0.228B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.210B 0.00
MDxHealth SA (MDXH) Belgium $0.167B 0.00
Nyxoah SA (NYXH) Belgium $0.158B 0.00
Health Catalyst (HCAT) United States $0.152B 0.00
CareCloud (CCLD) United States $0.104B 5.70
Outset Medical (OM) United States $0.082B 0.00
American Well (AMWL) United States $0.073B 0.00
NetraMark Holdings (AINMF) Canada $0.065B 0.00
111 (YI) China $0.064B 0.00
Pulmonx (LUNG) United States $0.062B 0.00
HeartBeam (BEAT) United States $0.049B 0.00
EUDA Health Holdings (EUDA) Singapore $0.042B 0.00
Precipio (PRPO) United States $0.035B 0.00
Evaxion - (EVAX) Denmark $0.028B 0.00
Predictive Oncology (POAI) United States $0.020B 0.00
Lunai Bioworks (LNAI) United States $0.016B 0.00
P3 Health Partners (PIII) United States $0.015B 0.00
Movano (MOVE) United States $0.012B 0.00
HeartSciences (HSCS) United States $0.010B 0.00
ITonic Holdings (ITOC) China $0.007B 0.00
Bullfrog AI Holdings (BFRG) United States $0.007B 0.00
Strata Skin Sciences (SSKN) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.006B 0.00
PROFUSA (PFSA) United States $0.005B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Healthcare Triangle (HCTI) United States $0.001B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.001B 0.00